Magnesium Recall: FDA Announces Popular Supplement’s Removal
AI Generated Image

Magnesium Recall: FDA Announces Popular Supplement’s Removal

Yahoo health

Key Points:

  • Magnesium supplements gained popularity during the pandemic, with different forms serving various functions such as promoting sleep, acting as laxatives, relieving migraines, and relaxing muscles.
  • The FDA announced a recall on June 19 for nearly 14,000 bottles of Adndale magnesium glycinate gummies due to the presence of undeclared melatonin, which could intensify sleep effects.
  • The recalled product, manufactured by Dkiru LLC in Dublin, Ireland, includes specific lot numbers and expiration dates, and is classified as a Class II recall, indicating potential temporary or reversible health risks.
  • Excessive magnesium intake can cause gastrointestinal issues, low blood pressure, fatigue, and kidney problems, with recommended daily allowances being 400 mg for men and 320 mg for women.

Trending Business

Trending Technology

Trending Health